These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4223765)

  • 1. Unknown properties of the products of plasmin-degradation of fibrinogen and fibrin.
    Buluk K; Malofiejew M; Czokalo M
    Bull Acad Pol Sci Biol; 1966; 14(4):193-7. PubMed ID: 4223765
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of plasmin degradation products of fibrinogen (F.D.P.) on electrobiological processes in rat uterine muscle.
    Malofiejew M
    Bull Acad Pol Sci Biol; 1969; 17(3):185-8. PubMed ID: 4240596
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of products of plasma degradation of fibrinogen on the permeability of capillaries].
    Malofiejew M; Buluk K
    Pol Tyg Lek; 1968 Apr; 23(17):619-21. PubMed ID: 4233960
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the biological properties of some fibrinogen degradation products (FDP)].
    Malofiejew M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1968; 23():1-65. PubMed ID: 4310706
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of the anti-factor VIII effect of thrombin in plasma by the plasminolytic derivatives of fibrinogen and fibrin.
    Chandra S; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1973 Nov; 30(2):235-47. PubMed ID: 4272616
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electron microscopic study of the depolymerization process on unstabilized fibrin as affected by urea or monochloracetic acid].
    Ul'ianov AM; Zhitnikova ES
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (8):59-63. PubMed ID: 6226322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M; Chen JP
    Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple rapid method for the purification of D and E fragments of fibrinogen degradation by plasmin.
    Carvajal Z; Arocha-Pinango CL
    Haematologica; 1983; 68(3):336-40. PubMed ID: 6224723
    [No Abstract]   [Full Text] [Related]  

  • 9. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.
    Guo F; Liu J; Wang C; Liu N; Lu P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):942-6. PubMed ID: 19852936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure of fibrinogen in view of the properties and structure of proteolytic products of degradation by plasmin].
    Budzyński AZ
    Postepy Hig Med Dosw; 1969; 23(3):293-369. PubMed ID: 4240986
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinin-like activities of the synthetic low molecular weight fragment of fibrinogen degradation products.
    Takaki A; Yamaguchi T; Ohsato K
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):350-5. PubMed ID: 4281115
    [No Abstract]   [Full Text] [Related]  

  • 16. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The small caliber prosthesis provided healing characteristics by plasmin-treated fibrin: preliminary report].
    Shinhara R; Fukuda Y; Haruta N; Kagawa N; Dohi K; Takano Y; Ezaki Y
    Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1452. PubMed ID: 1448054
    [No Abstract]   [Full Text] [Related]  

  • 18. Monocytic cell adhesion to intact and plasmin-modified fibrinogen: possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54).
    Arefieva TL; Krasnikova TL
    J Cell Physiol; 2001 Sep; 188(3):403-9. PubMed ID: 11473367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fibrinogen degradation products on plasmin activity.
    Myśliwiec M; Arnesen H; Godal HC
    Thromb Diath Haemorrh; 1973 Jun; 29(3):592-7. PubMed ID: 4271546
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective action of alpha 2-macroglobulin-plasmin complex fibrin.
    Veremeenko KN; Kizim AI
    Thromb Res; 1981 Aug; 23(3):317-22. PubMed ID: 6458120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.